Germany
Japan
United Kingdom
China
USD 380.00
4 Weeks
Mouse Monoclonal Ferritin Light Chain Antibody
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
Products
View as table Download
Mouse Monoclonal Leptin Antibody
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
Mouse Monoclonal Leptin Antibody
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
Mouse Monoclonal NGAL Antibody
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
Rabbit polyclonal anti Angiotensin II, neat antiserum
| Applications | ELISA |
| Reactivities | Human, Mammalian |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-OH coupled to carrier protein. |
Bradykinin; neat antiserum
| Applications | ELISA |
| Reactivities | Human, Mammalian |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH coupled to a carrier protein. |
Atrial Natriuretic Factor (1-28) (hu, bo, po); neat antiserum
| Applications | ELISA |
| Reactivities | Human, Bovine, Porcine |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide H-Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met- Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OH (Disulfide bond) coupled to carrier protein. |
BNP-32 (hu); neat antiserum
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide H-Ser-Pro-Lys-Met-Val-Gln-Gly-Ser-Gly-Cys-Phe-Gly- Arg-Lys-Met-Asp-Arg-Ile-Ser-Ser-Ser-Ser-Gly-Leu-Gly-Cys-Lys-Val-Leu- Arg-Arg-His-OH, (Disulfide bond) coupled to carrier protein. |
Corticotropin-Releasing Factor (CRF), rabbit anti human/mouse/rat, polyclonal, diluted Antiserum for RIA.
| Applications | ELISA |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide H-Ser-Glu-Glu-Pro-Pro-Ile-Ser-Leu-Asp-Leu-Thr- Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Met-Ala-Arg-Ala-Glu-Gln- Leu-Ala-Gln-Gln-Ala-His-Ser-Asn-Arg-Lys-Leu-Met-Glu-Ile-Ile-NH2 coupled to carrier protein. |
beta-Endorphin (hu); neat antiserum
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide H-Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr- Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-Tyr-Lys-Lys- Gly-Glu-OH coupled to carrier protein. |
Rabbit polyclonal anti human / mouse / rat Corticotropin-Releasing Factor (CRF)
| Applications | ELISA |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide H-Ser-Glu-Glu-Pro-Pro-Ile-Ser-Leu-Asp-Leu-Thr-Phe- His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Met-Ala-Arg-Ala-Glu-Gln-Leu-Ala-Gln- Gln-Ala-His-Ser-Asn-Arg-Lys-Leu-Met-Glu-Ile-Ile-NH2 coupled to carrier protein. |
Endothelin-1, rabbit anti human/bovine/dog/mouse/porcine/rat, polyclonal.
| Applications | ELISA |
| Reactivities | Human, Bovine, Dog, Mouse, Porcine, Rat |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide H-Cys-Ser-Cys-Ser-Ser-Leu-Met-Asp-Lys-Glu-Cys- Val-Tyr-Phe-Cys-His-Leu-Asp-Ile-Ile-Trp-OH, (Disulfide bonds between Cys1 and Cys15/Cys3 and Cys11) coupled to carrier protein. |
Gastric Inhibitory Polypeptide (hu); neat antiserum
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide H-Tyr-Ala-Glu-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile- Ala-Met-Asp-Lys-Ile-His-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln- Lys-Gly-Lys-Lys-Asn-Asp-Trp-Lys-His-Asn-Ile-Thr-Gln-OH coupled to carrier protein. |
Orexin B (hu); neat antiserum
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide H-Arg-Ser-Gly-Pro-Pro-Gly-Leu-Gln-Gly-Arg-Leu-Gln- Arg-Leu-Leu-Gln-Ala-Ser-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Met-NH2 coupled to carrier protein. |
Rabbit polyclonal anti Oxytocin
| Applications | ELISA |
| Reactivities | Human, Mammalian |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide H-Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2, (Disulfide bond) coupled to carrier protein. |
Rabbit polyclonal anti Pancreatic Polypeptide (hu); neat antiserum
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide H-Ala-Pro-Leu-Glu-Pro-Val-Tyr-Pro-Gly-Asp-Asn-Ala- Thr-Pro-Glu-Gln-Met-Ala-Gln-Tyr-Ala-Ala-Asp-Leu-Arg-Arg-Tyr-Ile-Asn- Met-Leu-Thr-Arg-Pro-Arg-Tyr-NH2 coupled to carrier protein. |
Rabbit polyclonal anti Peptide YY (hu); neat antiserum
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide H-Tyr-Pro-Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala- Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu- Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr-NH2 coupled to a carrier protein. |
Rabbit polyclonal anti Somatostatin-14
| Applications | ELISA |
| Reactivities | Human, Mammalian |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide H-Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe- Thr-Ser-Cys-OH (Disulfide bond) coupled to carrier protein. |
Rabbit polyclonal anti Somatostatin-14
| Applications | ELISA |
| Reactivities | Human, Mammalian |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide H-Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe- Thr-Ser-Cys-OH (Disulfide bond) coupled to carrier protein. |
Rabbit polyclonal anti pTH (1-34) (hu); neat antiserum
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide H-Ser-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly- Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu- Gln-Asp-Val-His-Asn-Phe-OH (Disulfide bond) coupled to carrier protein. |
Rabbit polyclonal anti Substance P
| Applications | ELISA |
| Reactivities | Human, Mammalian |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide H-Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu- Met-NH2 coupled to carrier protein. |
Rabbit polyclonal anti ACTH (1-24) (hu, bo, rt); purified rabbit IgG
| Applications | ELISA |
| Reactivities | Human, Bovine, Mouse, Porcine, Rabbit, Rat |
| Conjugation | Unconjugated |
Rabbit polyclonal anti ACTH (1-39) (hu); neat antiserum
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
Rabbit polyclonal anti ACTH (18-39) (hu); neat antiserum
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide H-Arg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Gly-Ala-Glu-Asp- Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe-OH coupled to carrier protein. |
Rabbit polyclonal anti ACTH (1-24) (hu, bo, rt); neat antiserum
| Applications | ELISA |
| Reactivities | Human, Bovine, Mouse, Porcine, Rabbit, Rat |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide H-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-LysPro- Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-OH (Disulfide bond) carrier protein. |
Rabbit polyclonal anti VIP (hu, ms, rt); diluted antiserum
| Applications | ELISA |
| Reactivities | Human, Bovine, Porcine, Rat |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide H-His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg- Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn-NH2 coupled to a carrier protein. |
Rabbit polyclonal anti human Amylin
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide H-Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu- Ala-Asn-Phe-Leu-Val-Arg-Ser-Ser-Asn-Asn-Leu-Gly-Pro-Val-Leu-Pro- Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2, (Disulfide bond) coupled to carrier protein. |
Rabbit polyclonal anti Amylin (1-13) (hu); neat antiserum
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide H-Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu- Ala-NH2, (disulfide bond) coupled to carrier protein. |
Rabbit polyclonal anti Angiotensin I; purified rabbit IgG
| Applications | ELISA |
| Reactivities | Human, Mammalian |
| Conjugation | Unconjugated |
Amylin (25-37), rabbit anti human, polyclonal.
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide H-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly-Ser-Asn-NH2 coupled to carrier protein. |
Angiotensin I, rabbit anti Angiotensin I, polyclonal.
| Applications | ELISA |
| Reactivities | Human, Mammalian |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-OH coupled to carrier protein. |
Rabbit polyclonal anti Amylin (25-37) (hu); neat antiserum
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide H-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly-Ser-Asn-NH2 coupled to carrier protein. |
Rabbit polyclonal anti b-Atrial Natriuretic Factor (1-28) (Dimer, Antiparallel) (hu); neat antiserum
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide H-Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met- Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OH (Disulfide bond linked dimer) coupled to a carrier protein. |
Rabbit polyclonal anti human Amylin
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide H-Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg- Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-Phe-Gly-Ala-Ile- Leu-Ser-Ser-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2, (disulfide bond) coupled to carrier protein. |
Rabbit polyclonal anti Prepro-Atrial Natriuretic Factor (104-123) (hu); neat antiserum
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide H-Ser-Ser-Asp-Arg-Ser-Ala-Leu-Leu-Lys-Ser-Lys-Leu- Arg-Ala-Leu-Leu-Thr-Ala-Pro-Arg-OH coupled to carrier protein. |
Rabbit polyclonal anti Bombesin; neat antiserum
| Applications | ELISA |
| Reactivities | Human, Mammalian |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide Pyr-Gln-Arg-Leu-Gly-Asn-Gln-Trp-Ala-Val-Gly-His- Leu-Met-NH2 coupled to carrier protein. |
Rabbit polyclonal anti human / porcine / rat C-Type Natriuretic Peptide (CNP) (32-53)
| Applications | ELISA |
| Reactivities | Human, Porcine, Rat |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide H-Gly-Leu-Ser-Lys-Gly-Cys-Phe-Gly-Leu-Lys-Leu- Asp-Arg-Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys-OH (disulfide bond) coupled to carrier protein. |
Rabbit polyclonal anti Calcitonin (hu); neat antiserum
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide H-Cys-Gly-Asn-Leu-Ser-Thr-Cys-Met-Leu-Gly-Thr-Tyr- Thr-Gln-Asp-Phe-Asn-Lys-Phe-His-Thr-Phe-Pro-Gln-Thr-Ala-Ile-Gly-Val- Gly-Ala-Pro-NH2, (Disulfide bond) coupled to carrier protein. |
Rabbit polyclonal anti C-Type Natriuretic Peptide (32-53) (hu, po, rt); neat antiserum
| Applications | ELISA |
| Reactivities | Human, Porcine, Rat |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide H-Gly-Leu-Ser-Lys-Gly-Cys-Phe-Gly-Leu-Lys-Leu- Asp-Arg-Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys-OH, (Disulfide bond) coupled to carrier protein. |
Rabbit polyclonal anti human Calcitonin Gene-Related Peptide 1 (alpha-CGRP)
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide H-Cys-Gly-Asn-Leu-Ser-Thr-Cys-Met-Leu-Gly-Thr-Tyr- Thr-Gln-Asp-Phe-Asn-Lys-Phe-His-Thr-Phe-Pro-Gln-Thr-Ala-Ile-Gly-Val- Gly-Ala-Pro-NH2, (Disulfide bond) coupled to carrier protein. |
Rabbit polyclonal anti b-CGRP (hu); neat antiserum
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide H-Ala-Cys-Asn-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu- Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Met-Val-Lys-Ser-Asn-Phe-Val- Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2, (Disulfide bond) coupled to carrier protein. |
Rabbit polyclonal anti VIP (hu, ms, rt); neat antiserum
| Applications | ELISA |
| Reactivities | Human, Bovine, Porcine, Rat |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide H-His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg- Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn-NH2 coupled to carrier protein. |
Rabbit polyclonal anti Pancreastatin (33-48) (hu); neat antiserum
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide H-Glu-Glu-Glu-Glu-Glu-Met-Ala-Val-Val-Pro-Gln-Gly- Leu-Phe-Arg-Gly-NH2 coupled to carrier protein. |
Rabbit polyclonal anti Dynorphin A; neat antiserum
| Applications | ELISA |
| Reactivities | Human, Mammalian |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide H-Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu- Lys-Trp-Asp-Asn-Gln-OH coupled to carrier protein. |
Rabbit polyclonal anti Dynorphin A (1-13); neat antiserum
| Applications | ELISA |
| Reactivities | Human, Mammalian |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide H-Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu- Lys-OH coupled to carrier protein. |
Rabbit polyclonal anti Dynorphin B; neat antiserum
| Applications | ELISA |
| Reactivities | Human, Mammalian |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide H-Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Gln-Phe-Lys-Val-Val- Thr-OH coupled to carrier protein. |
Rabbit polyclonal anti Met-Enkephalin; neat antiserum
| Applications | ELISA |
| Reactivities | Human, Mammalian |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide H-Try-Gly-Gly-Phe-Met-OH coupled to carrier protein. |
Rabbit polyclonal anti Neurotensin; neat antiserum
| Applications | ELISA |
| Reactivities | Human, Mammalian |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide Pyr-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu- OH coupled to carrier protein. |
Rabbit polyclonal anti human Galanin
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide H-Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly- Pro-His-Ala-Val-Gly-Asn-His-Arg-Ser-Phe-Ser-Asp-Lys-Asn-Gly-Leu- Thr-Ser-OH coupled to carrier protein. |
Rabbit polyclonal anti Gastrin I (hu); neat antiserum
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide Pyr-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly- Trp-Met-Asp-Phe-NH2 coupled to carrier protein. |
Active filters
Reactivities
- Human
Assay Types
- Indirect
Filter by
Category
Target Symbol
- H3C1 (36)
- MAPT (24)
- NPPA (22)
- POMC (20)
- PDYN (18)
- EDN1 (15)
- GCG (14)
- PENK (14)
- PTH (13)
- CALCA (10)
- MUC1 (10)
- ADCYAP1 (9)
- H4-16 (9)
- TNF (9)
- AGT (8)
- AVP (8)
- CCR5 (8)
- APP (7)
- CD4 (7)
- EGFR (7)
- IAPP (7)
- SST (7)
- TAC1 (7)
- CD52 (6)
- IGF1 (6)
- INS (6)
- MSLN (6)
- VEGFA (6)
- VIP (6)
- ADM (5)
- CD80 (5)
- CORT (5)
- CRH (5)
- ERBB2 (5)
- GAL (5)
- GAST (5)
- GHRH (5)
- GHRL (5)
- GNRH1 (5)
- H3-3A (5)
- NMU (5)
- AOC3 (4)
- BLM (4)
- CD44 (4)
- FN1 (4)
- GRP (4)
- IL2RA (4)
- INSR (4)
- ITGB2 (4)
- NOTCH2 (4)
- PTHLH (4)
- PXN (4)
- TNFRSF8 (4)
- TOR2A (4)
- BOMBESIN (3)
- CALCB (3)
- CCK (3)
- CD40 (3)
- DNMT3A (3)
- GIP (3)
- H-PHE-MET-ARG-PHE-NH2 (3)
- H2BC5 (3)
- HCRT (3)
- HRCT (3)
- ITGA5 (3)
- KISS1 (3)
- KNG1 (3)
- LEY (3)
- NPPB (3)
- NPPC (3)
- NPY (3)
- NTS (3)
- OXT (3)
- PPY (3)
- PYY (3)
- SLC3A2 (3)
- TYRP1 (3)
- UTS2 (3)
- ACKR1 (2)
- ADRB2 (2)
- AGER (2)
- AKT1 (2)
- ALBUMIN (2)
- ANGIOTENSIN A (2)
- APLN (2)
- ARHGAP22 (2)
- BAGE (2)
- BGLAP (2)
- C3AR1 (2)
- C5AR1 (2)
- CALCITONIN N-TERMINAL FLANKING PEPTIDE (2)
- CD1A (2)
- CD28 (2)
- CD40LG (2)
- CD55 (2)
- CD74 (2)
- CD81 (2)
- CHGA (2)
- CR1 (2)
- CYSTATIN C (2)
Applications
Antibody Hosts
Isotypes
Clonalities
Conjugates
Modifications
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (40)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human Fab format, for improved compatibility with existing reagents, assays and techniques. (17)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (12)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (9)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (7)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques. (7)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques. (7)
- This full-length, chimeric rabbit antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. (5)
- This full-length, chimeric rabbit antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques. (5)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (4)
- This full-length, reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques. (4)
- This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (4)
- This chimeric rabbit antibody was made using the variable domain sequences of the original human scFv format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2a format, for improved compatibility with existing reagents, assays and techniques. (3)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (3)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (2)
- This full-length, chimeric mouse antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. (2)
- This full-length, reformatted human antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. (2)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This reformatted human antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric murine antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgM format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG3 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse scFv antibody fragment format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2a format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG3 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This is a chimeric mouse antibody, based on the original rat IgG2b format, created for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG3 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv antibody fragment format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original mouse scFv format for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted rat antibody was made using the variable domain sequences of the original Rat IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
Families
- Druggable Genome (58)
- Transcription Factors (18)
- Secreted Protein (6)
- ES Cell Differentiation/IPS (4)
- Induced pluripotent stem cells (3)
- Transmembrane (3)
- Embryonic stem cells (2)
- Nuclear Hormone Receptor (2)
- Stem cell - Pluripotency (2)
- Protease (1)
- Stem cell relevant signaling - TGFb/BMP signaling pathway (1)
Pathways
- Systemic lupus erythematosus (52)
- Alzheimer's disease (24)
- MAPK signaling pathway (24)
- Pathways in cancer (7)
- Acute myeloid leukemia (5)
- Cysteine and methionine metabolism (5)
- Metabolic pathways (5)
- Cytokine-cytokine receptor interaction (3)
- PPAR signaling pathway (3)
- Adipocytokine signaling pathway (2)
- Jak-STAT signaling pathway (2)
- Neuroactive ligand-receptor interaction (2)
- Base excision repair (1)
- Bladder cancer (1)
- Chemokine signaling pathway (1)
- Chronic myeloid leukemia (1)
- Epithelial cell signaling in Helicobacter pylori infection (1)
- Huntington's disease (1)
- Lysine degradation (1)
- NOD-like receptor signaling pathway (1)
- RIG-I-like receptor signaling pathway (1)
- RNA degradation (1)
- Thyroid cancer (1)
- Tight junction (1)
- Toll-like receptor signaling pathway (1)
- Ubiquitin mediated proteolysis (1)
- Vascular smooth muscle contraction (1)
- Viral myocarditis (1)